LRRK2 and pulmonary fibrosis: However, due to the tissue-specific expression of LRRK2, inhibitors targeting LRRK2 may not always be protective; for example, the reduction of LRRK2 levels could lead to pulmonary fibrosis (Hu et al., 2023; Tian et al., 2021).